These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 15645685

  • 1. Virological issues in the use of cell therapies.
    Minor PD.
    Dev Biol (Basel); 2004; 118():151-3. PubMed ID: 15645685
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Considerations in performing virus spiking experiments and process validation studies.
    Darling AJ.
    Dev Biol Stand; 1993; 81():221-9. PubMed ID: 8174806
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The clearance of viruses and transmissible spongiform encephalopathy agents from biologicals.
    Farshid M, Taffs RE, Scott D, Asher DM, Brorson K.
    Curr Opin Biotechnol; 2005 Oct; 16(5):561-7. PubMed ID: 16095899
    [Abstract] [Full Text] [Related]

  • 10. Theoretical and technical concerns in inactivation/elimination of viruses in plasma derivatives.
    Hilfenhaus J, Niedrig M, Nowak T.
    Dev Biol Stand; 1993 Oct; 81():117-23. PubMed ID: 8174794
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Animal virus contaminants of biotechnology products.
    Onions D.
    Dev Biol (Basel); 2004 Oct; 118():155-63. PubMed ID: 15645686
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Detection of adventitious viruses in biologicals--a rare occurrence.
    Nims RW.
    Dev Biol (Basel); 2006 Oct; 123():153-64; discussion 183-97. PubMed ID: 16566443
    [Abstract] [Full Text] [Related]

  • 16. Biosafety and product release testing issues relevant to replication-competent oncolytic viruses.
    Wisher M.
    Cancer Gene Ther; 2002 Dec; 9(12):1056-61. PubMed ID: 12522444
    [Abstract] [Full Text] [Related]

  • 17. Human retroviruses and herpesviruses: problems and solutions in safety testing of biologicals.
    Onions D, Lees G.
    Dev Biol Stand; 1991 Dec; 75():145-58. PubMed ID: 1794616
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Process changes and their effect on process evaluation for viral clearance.
    Marcus-Sekura C.
    Dev Biol Stand; 1996 Dec; 88():125-30. PubMed ID: 9119123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.